SCHEMBL9242590

SCHEMBL9242590

Cn1c(OC(=O)O)cc2cc(Cl)ccc21

nearest known ligand 0.52

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.52
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
PHGDH O43175 10/20 0.46
AHR P35869 1/20 0.42
CCR2 P41597 1/20 0.41
KMO O15229 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9237671 0.81 LMNA (0.50) RXFP1MEN1KMT2APHGDH
SCHEMBL9241443 0.81 CCR2 (0.45) RXFP1MEN1KMT2APHGDHCCR2
SCHEMBL9243614 0.81 KDM4E (0.60) MEN1KMT2ACCR2
SCHEMBL9243077 0.81 CCR2 (0.47) RXFP1MEN1KMT2APHGDHCCR2
SCHEMBL10970037 0.81 RXFP1 (0.49) RXFP1MEN1KMT2APHGDHAHR
SCHEMBL9235979 0.80 KDM4E (0.64) MEN1KMT2A
SCHEMBL9239380 0.79 CCR2 (0.44) RXFP1MEN1KMT2ACCR2
SCHEMBL4198025 0.79 MCL1 (0.57) MEN1KMT2APHGDH
SCHEMBL43328 0.76 KDM4E (0.66) RXFP1MEN1KMT2APHGDHAHR
SCHEMBL6001817 0.74 MAPK1 (0.43) RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2999469-A1 PHARMACEUTICAL COMPOSITION AND THE USE THEREOF, AND APPLICATION REGIME OF SAID PHARMACEUTICAL COMPOSITION FOR ON-DEMAND CONTRACEPTION Bayer Pharma Aktiengesellschaft (DE) 2016-03-30 EP disclosed
WO-2014187744-A1 PHARMACEUTICAL COMPOSITION AND THE USE THEREOF, AND APPLICATION REGIME OF SAID PHARMACEUTICAL COMPOSITION FOR ON-DEMAND CONTRACEPTION BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-11-27 WO disclosed
EP-0639573-A1 Benzocondensed five membered heterocycles, process of their preparation, their use as drug, as diagnostic means and pharmaceuticals containing it HOECHST AKTIENGESELLSCHAFT (DE) 1995-02-22 EP disclosed